Education
About Us
Working with TipRanks
Follow Us
Grand Pharmaceutical Group Limited (HK:0512)
:0512
RESEARCH TOOLSreports
Total Valuation
Grand Pharmaceutical Group Limited has a market cap or net worth of HK$30.63B. The enterprise value is HK$14.78B.
Market CapHK$30.63B
Enterprise ValueHK$14.78B
Share Statistics
Grand Pharmaceutical Group Limited has 3,549,571,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,549,571,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Grand Pharmaceutical Group Limited’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 8.71%.
Return on Equity (ROE)0.15
Return on Assets (ROA)0.10
Return on Invested Capital (ROIC)8.71%
Return on Capital Employed (ROCE)0.12
Revenue Per Employee971.46K
Profits Per Employee237.95K
Employee Count11,987
Asset Turnover0.47
Inventory Turnover3.58
Valuation Ratios
The current PE Ratio of Grand Pharmaceutical Group Limited is 6.81. Grand Pharmaceutical Group Limited’s PEG ratio is 0.27.
PE Ratio6.81
PS Ratio0.00
PB Ratio2.11
Price to Fair Value1.02
Price to FCF18.11
Price to Operating Cash Flow13.35
PEG Ratio0.27
Income Statement
In the last 12 months, Grand Pharmaceutical Group Limited had revenue of 11.64B and earned 2.47B in profits. Earnings per share was 0.70.
Revenue11.64B
Gross Profit6.74B
Operating Income2.17B
Pretax Income2.85B
Net Income2.47B
EBITDA3.39B
Earnings Per Share (EPS)0.70
Cash Flow
In the last 12 months, operating cash flow was 1.72B and capital expenditures -580.63M, giving a free cash flow of 1.14B billion.
Operating Cash Flow1.72B
Free Cash Flow1.14B
Free Cash Flow per Share0.32
Dividends & Yields
Grand Pharmaceutical Group Limited pays an annual dividend of HK$0.259, resulting in a dividend yield of 3.01%
Dividend Per ShareHK$0.259
Dividend Yield3.01%
Payout Ratio36.93%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.82
52-Week Price Change93.50%
50-Day Moving Average7.97
200-Day Moving Average5.48
Relative Strength Index (RSI)49.95
Average Volume (3m)36.59M
Important Dates
Grand Pharmaceutical Group Limited upcoming earnings date is Aug 6, 2025, TBA (Confirmed).
Last Earnings DateMar 12, 2025
Next Earnings DateAug 6, 2025
Ex-Dividend DateApr 14, 2025
Financial Position
Grand Pharmaceutical Group Limited as a current ratio of 1.22, with Debt / Equity ratio of 21.25%
Current Ratio1.22
Quick Ratio1.01
Debt to Market Cap0.26
Net Debt to EBITDA0.92
Interest Coverage Ratio12.05
Taxes
In the past 12 months, Grand Pharmaceutical Group Limited has paid 386.30M in taxes.
Income Tax386.30M
Effective Tax Rate0.14
Enterprise Valuation
Grand Pharmaceutical Group Limited EV to EBITDA ratio is 5.88, with an EV/FCF ratio of 15.60.
EV to Sales1.71
EV to EBITDA5.88
EV to Free Cash Flow15.60
EV to Operating Cash Flow10.49
Balance Sheet
Grand Pharmaceutical Group Limited has HK$3.14B in cash and marketable securities with HK$4.44B in debt, giving a net cash position of HK$1.30B billion.
Cash & Marketable SecuritiesHK$3.14B
Total DebtHK$4.44B
Net CashHK$1.30B
Net Cash Per ShareHK$0.37
Tangible Book Value Per ShareHK$3.63
Margins
Gross margin is 63.52%, with operating margin of 18.65%, and net profit margin of 21.20%.
Gross Margin63.52%
Operating Margin18.65%
Pretax Margin24.49%
Net Profit Margin21.20%
EBITDA Margin29.09%
EBIT Margin26.04%
Analyst Forecast
The average price target for Grand Pharmaceutical Group Limited is HK$6.20, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetHK$6.20
Price Target Upside-28.16% Downside
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast10.59%
EPS Growth Forecast31.83%